Amedeo Smart

Free Medical Literature Service

 

Amedeo

Contraception and Contraceptive Drugs
  Free Subscription

Articles published in
Obstet Gynecol
    August 2025
  1. PEARSON A, Shvartsman K, Zeng W, Brown J, et al
    Cost Effectiveness of Salpingectomy Compared With Vasectomy for Permanent Contraception.
    Obstet Gynecol. 2025 Aug 28. doi: 10.1097/AOG.0000000000006042.
    >> Share

  2. KUMASAKA JK, Mandelbaum AD, Edelman AB, Caughey AB, et al
    Cost Effectiveness of Over-the-Counter Availability of Progestin-Only Contraceptive Pills in Abortion-Restrictive and Abortion-Protective Settings.
    Obstet Gynecol. 2025 Aug 21. doi: 10.1097/AOG.0000000000006048.
    >> Share

    June 2025
  3. ARORA KS, Larkin S, Milne J, Carmona Clavijo G, et al
    Goals and Priorities of Community Members Regarding the Federally Mandated Medicaid Sterilization Policy.
    Obstet Gynecol. 2025;146:394-401.
    >> Share

    May 2025
  4. SMEREKA MI, Vivas-Valencia C, Testa A, Byrne JJ, et al
    Expanding Access to Quality Reproductive Health Care After the Dobbs v. Jackson Women's Health Organization Decision.
    Obstet Gynecol. 2025;146:195-201.
    >> Share

  5. KOU L, Huang C, Xiao D, Liao S, et al
    Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005923.
    >> Share

    March 2025
  6. YUK JS, Kim MH, Yoon SH, Han GH, et al
    Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence.
    Obstet Gynecol. 2025 Mar 13. doi: 10.1097/AOG.0000000000005881.
    >> Share

    February 2025
  7. CARMODY MD, Schultz AL, Berg KA, Bullington BW, et al
    Association Between Comorbidities and Inpatient Postpartum Permanent Contraception Completion.
    Obstet Gynecol. 2025 Feb 6. doi: 10.1097/AOG.0000000000005844.
    >> Share

  8. SOLOMON MD, Zaritsky EF, Warton M, Millman A, et al
    Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates.
    Obstet Gynecol. 2025;145:196-203.
    >> Share

    January 2025
  9. STEENLAND MW, Oviedo D, Bates MA, Zhou A, et al
    Effect of an Intensive Nurse Home Visiting Program on Postpartum Contraceptive Use and Birth Spacing: A Randomized Controlled Trial.
    Obstet Gynecol. 2025;145:3-12.
    >> Share

    December 2024
  10. FRIEDMAN M, Mor L, Shazar R, Paul N, et al
    Treatment of Early Pregnancy Loss With Mifepristone and Misoprostol Compared With Misoprostol Only.
    Obstet Gynecol. 2024 Dec 5. doi: 10.1097/AOG.0000000000005800.
    >> Share


  11. ACOG Committee Statement No. 13: Self-Managed Abortion.
    Obstet Gynecol. 2024;144:e152-e159.
    >> Share

    November 2024
  12. SOLOMON MD, Zaritsky EF, Warton M, Millman A, et al
    Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates.
    Obstet Gynecol. 2024 Nov 1. doi: 10.1097/AOG.0000000000005796.
    >> Share

    September 2024
  13. CASTANO PM
    Postpartum Long-Acting Reversible Contraception: Cost Effectiveness and Patient Desires in a Larger Context.
    Obstet Gynecol. 2024;144:291-293.
    >> Share

    August 2024
  14. WERNICK HJ, Abdel-Rasoul M, Berlan ED, Bonny AE, et al
    Body Mass Index Changes Among Adolescents and Young Adults Using the Etonogestrel Contraceptive Implant.
    Obstet Gynecol. 2024 Aug 30. doi: 10.1097/AOG.0000000000005712.
    >> Share


  15. Rates of Female Sterilization, Vasectomy, and LARC Placement Before and After the Dobbs Decision: A Retrospective Cohort Study [ID 2683404].
    Obstet Gynecol. 2024;144:e46.
    >> Share

    July 2024
  16. BULLARD KA, Ramanadhan S, Caughey AB, Rodriguez MI, et al
    Immediate Postpartum Long-Acting Reversible Contraception for Preventing Severe Maternal Morbidity: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2024 Jul 25. doi: 10.1097/AOG.0000000000005679.
    >> Share

  17. SIMMONS RG, Carter G, Sanders JN, Turok DK, et al
    Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study.
    Obstet Gynecol. 2024;144:79-88.
    >> Share

    May 2024
  18. SIMMONS RG, Carter G, Sanders JN, Turok DK, et al
    Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005621.
    >> Share

  19. MEYER R, Toussia-Cohen S, Shats M, Segal O, et al
    24-Hour Compared With 12-Hour Mifepristone-Misoprostol Interval for Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005535.
    >> Share

    April 2024
  20. MURPHY E, Pelletier A, Fay K, Bartz D, et al
    National Postpartum Permanent Contraception Practices and Perceived Barriers.
    Obstet Gynecol. 2024 Apr 16. doi: 10.1097/AOG.0000000000005584.
    >> Share

    February 2024

  21. Permanent Contraception: Ethical Issues and Considerations: ACOG Committee Statement No. 8.
    Obstet Gynecol. 2024;143:e31-e39.
    >> Share

    January 2024
  22. BAUERFEIND A, von Stockum S, Boehnke T, Heinemann K, et al
    Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
    Obstet Gynecol. 2024 Jan 16. doi: 10.1097/AOG.0000000000005509.
    >> Share

  23. KRASHIN JW, Black P, Brannen E, Gard CC, et al
    Geographic Access to Early Pregnancy Loss Management.
    Obstet Gynecol. 2024 Jan 11. doi: 10.1097/AOG.0000000000005505.
    >> Share


  24. ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression: Correction.
    Obstet Gynecol. 2024;143:e20.
    >> Share

    December 2023
  25. IZATT A, Greenberg RA, Thorne J, Erdman J, et al
    Ethical and Legal Considerations for Sterilization Refusal in Nulliparous Women.
    Obstet Gynecol. 2023;142:1316-1321.
    >> Share

  26. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    >> Share

  27. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    >> Share

    November 2023
  28. RAMANADHAN S, Jensen J
    The Levonorgestrel-Releasing Intrauterine Device as Emergency Contraception: Re-examining the Data.
    Obstet Gynecol. 2023 Nov 21. doi: 10.1097/AOG.0000000000005466.
    >> Share

  29. ALLEN RH, Bartz D
    Opill: The Over-the-Counter Contraceptive Pill.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005455.
    >> Share

  30. EBERLE A, Nguyen DB, Smith JP, Mansour FW, et al
    Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005444.
    >> Share

    October 2023
  31. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005421.
    >> Share

  32. HENKEL A, Miller HE, Zhang J, Lyell DJ, et al
    Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005259.
    >> Share


  33. Association of the Cervicovaginal Microbiome With Contraceptive Methods in Hispanic Women Living in Puerto Rico [ID: 1376364]: Correction.
    Obstet Gynecol. 2023;142:996.
    >> Share

    September 2023
  34. BULLINGTON BW, Berg KA, Miller ES, Boozer M, et al
    Association Among Race, Ethnicity, Insurance Type, and Postpartum Permanent Contraception Fulfillment.
    Obstet Gynecol. 2023 Sep 7. doi: 10.1097/AOG.0000000000005328.
    >> Share

    August 2023
  35. DARNEY BG, Biel FM, Oakley J, Coleman-Minahan K, et al
    Contraceptive Method Switching and Long-Acting Reversible Contraception Removal in U.S. Safety Net Clinics, 2016-2021.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005277.
    >> Share

  36. FASSETT MJ, Reed SD, Rothman KJ, Pisa F, et al
    Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005299.
    >> Share

    July 2023
  37. MOSESON H, Jayaweera R, Egwuatu I, Grosso B, et al
    Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.
    Obstet Gynecol. 2023 Jul 6. doi: 10.1097/AOG.0000000000005266.
    >> Share


  38. Medicaid and Fulfillment of Postpartum Permanent Contraception Requests: Correction.
    Obstet Gynecol. 2023;142:221-222.
    >> Share


  39. Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5: Correction.
    Obstet Gynecol. 2023;142:221.
    >> Share

    May 2023
  40. VALERIE F
    Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness.
    Obstet Gynecol. 2023 May 24. doi: 10.1097/AOG.0000000000005253.
    >> Share

  41. QURESHEY EJ, Ibarra CJ, Wagner SM, Chen HY, et al
    Effect of a Multimedia Educational Tool on Contraception Use 1 Year Postpartum.
    Obstet Gynecol. 2023 May 4. doi: 10.1097/AOG.0000000000005198.
    >> Share

  42. ARORA KS, Chua A, Miller E, Boozer M, et al
    Medicaid and Fulfillment of Postpartum Permanent Contraception Requests.
    Obstet Gynecol. 2023;141:918-925.
    >> Share

  43. NEBLETT MF 2ND, Stewart EA
    Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
    Obstet Gynecol. 2023;141:901-910.
    >> Share

    April 2023
  44. PEARLMAN SHAPIRO M, Myo M, Chen T, Nathan A, et al
    Remote Provision of Medication Abortion and Contraception Through Telemedicine.
    Obstet Gynecol. 2023 Apr 13. doi: 10.1097/AOG.0000000000005205.
    >> Share

  45. CREININ MD, Jensen JT, Chen MJ, Black A, et al
    Combined Oral Contraceptive Adherence and Pregnancy Rates.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005155.
    >> Share

  46. CREININ MD, Barnhart KT, Gawron LM, Eisenberg D, et al
    Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005137.
    >> Share

  47. CHEN BA, Kimble T, Harris LH, Kerns JL, et al
    Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005147.
    >> Share

  48. SUZUKI Y, Chen L, Hou JY, St Clair CM, et al
    Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005124.
    >> Share


  49. Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5.
    Obstet Gynecol. 2023;141:866-872.
    >> Share

    March 2023
  50. SCHWARTZ BI, Bear B, Short VL, Kazak AE, et al
    Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005123.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016